MYNX CONTROL Vascular Closure Device
MYNX CONTROL Vascular Closure Device
MYNX CONTROL Vascular Closure Device by Cordis
The MYNX CONTROL Vascular Closure Device by Cordis is a next-generation femoral arteriotomy closure system that integrates dual-mode active sealing with a fully resorbable polyethylene glycol (PEG) sealant plug. It enables rapid hemostasis at 5F–7F arterial access sites while leaving no permanent implant — the sealant is naturally resorbed by the body within 30 days.
Designed for predictable deployment, enhanced patient comfort, and reduced time-to-ambulation compared to manual compression, the MYNX CONTROL is indicated for use following diagnostic and interventional percutaneous cardiovascular procedures. Cleared under FDA 510(k) for use in US catheterization labs, it represents the gold standard in vascular access site management for modern cath lab and hybrid OR environments.
Key Features
- Dual-mode active sealing for rapid, reliable hemostasis
- Fully resorbable PEG sealant plug — naturally absorbed within 30 days
- No permanent implant left at the access site
- Compatible with 5F–7F femoral arterial access sites
- Reduces time-to-ambulation vs. manual compression
- FDA 510(k) cleared for diagnostic and interventional cardiovascular procedures
- Ergonomic delivery handle for intuitive, single-operator deployment
Product Gallery
Specifications
| Specification | Details |
|---|---|
| Compatible Access Size | 5F – 7F femoral arterial access |
| Sealant Material | Polyethylene Glycol (PEG) — fully bioabsorbable |
| Resorption Time | Approximately 30 days |
| Arteriotomy Site | Common femoral artery |
| Sterility | Sterile, single-use — do not resterilize |
| FDA Clearance | FDA 510(k) cleared |
| Indicated Procedures | Diagnostic and interventional percutaneous cardiovascular procedures |